<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05115877</url>
  </required_header>
  <id_info>
    <org_study_id>031.HPB.2020.R</org_study_id>
    <nct_id>NCT05115877</nct_id>
  </id_info>
  <brief_title>Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases</brief_title>
  <official_title>Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Methodist Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Methodist Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be a retrospective, registry study collecting data of patients who were&#xD;
      diagnosed with benign or malignant gastrointestinal diseases. Data will be collected from&#xD;
      patient's chart retrospectively once the patients have completed proper treatment follow up&#xD;
      with physicians' practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is reported in the literature that the treatment of any gastrointestinal disease process,&#xD;
      whether benign or malignant, continues to be a huge challenge. For example, patients with&#xD;
      gastrointestinal cancer continue to be diagnosed at an advanced stage with medical and&#xD;
      surgical options that are improving in terms of outcome measurements but with much more room&#xD;
      for improvement. The goal is to continue to review our treatment outcomes to further improve&#xD;
      overall survival, overall symptom control, mortality and morbidity.&#xD;
&#xD;
      The main aim of this study is to evaluate and compare the outcomes from our treatment of&#xD;
      benign or malignant gastrointestinal diseases through medical chart review.&#xD;
&#xD;
      There is a need to understand and improve the current diagnosis and treatment algorithm for&#xD;
      gastrointestinal pathologies. Continued evaluation and study is imperative to ensure that&#xD;
      national guidelines are improving to enhance patient cure and/or recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 7, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>Jan 2005 - Jan 2030</time_frame>
    <description>from day of diagnosis or procedure to death date</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall symptom</measure>
    <time_frame>Jan 2005 - Jan 2030</time_frame>
    <description>Difficulty swallowing, Heartburn, Regurgitation, Chest pain, Weight Loss, Quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Jan 2005 - Jan 2030</time_frame>
    <description>death or life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>Jan 2005 - Jan 2030</time_frame>
    <description>yes or no to individual disease</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Gastrointestinal Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who were diagnosed with benign or malignant gastrointestinal diseases.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients diagnosed and treated for gastrointestinal diseases, benign or malignant&#xD;
             from 2005 to 2030.&#xD;
&#xD;
          -  Age â‰¥18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients that are not diagnosed with or treated for gastrointestinal diseases&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dhiresh R Jeyarajah</last_name>
    <role>Principal Investigator</role>
    <affiliation>Methodist Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Methodist Richardson Medical Center</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <zip>75082</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 18, 2020</study_first_submitted>
  <study_first_submitted_qc>November 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

